Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals (Q34603893)

3 August 2017

title

Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals (English)

1 reference

3 August 2017

1 reference

E L Carey

1

1 reference

3 August 2017

H J Duff

2

1 reference

3 August 2017

D M Roden

3

1 reference

3 August 2017

R K Primm

4

1 reference

3 August 2017

G R Wilkinson

5

1 reference

3 August 2017

T Wang

6

1 reference

3 August 2017

J A Oates

7

1 reference

3 August 2017

R L Woosley

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 1984

1 reference

Journal of Clinical Investigation

3 August 2017

published in

1 reference

3 August 2017

volume

73

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

539-547

1 reference

The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Acetylator phenotype and lupus erythematosus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Defective metabolism of metoprolol in poor hydroxylators of debrisoquine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Lidocaine and its active metabolites

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Clinical experience of encainide (MJ 9067): A new anti-arrhythmic drug

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Some statistical methods useful in circulation research.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Genetic polymorphism of phenformin 4-hydroxylation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=425046

Polymorphism of carbon oxidation of drugs and clinical implications

26 October 2018

1 reference

12 December 2020

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics

1 reference

12 December 2020

Procainamide delivery to ischemic canine myocardium following rapid intravenous administration

1 reference

12 December 2020

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide

1 reference

12 December 2020

Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia

1 reference

12 December 2020

Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation

1 reference

12 December 2020

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

1 reference

12 December 2020

Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias

1 reference

12 December 2020

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

1 reference

12 December 2020

Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers

1 reference

12 December 2020

High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation

1 reference

12 December 2020

Metabolite cumulation during long-term oral encainide administration

1 reference

12 December 2020

Electrophysiology of oral encainide

1 reference

12 December 2020

Antiarrhythmic activity of the O-demethyl metabolite of encainide

1 reference

12 December 2020

Relationship between the pharmacokinetics and pharmacodynamics of procainamide

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI111241

1 reference

3 August 2017

1 reference

3 August 2017

1 reference